Part:BBa_K4712081
covid-19-R1
The primers were designed using NCBI BLAST and SanpGene to achieve efficient and specific amplification. This primer in RPA serves as the initial binding point for the amplification process, ensuring the specificity of the reaction by targeting the desired Severe acute respiratory syndrome coronavirus 2 DNA or RNA sequences. The primers provided data for mathematical modeling for further primer design.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Protocol: 1. For a 20μL reaction system:
| Reagent | Stock Concentration | Volume Added（μL） |
|---|---|---|
| Forward Primer | 10μM | 1 |
| Reverse Primer | 10μM | 1 |
| Rehydration Buffer (2X) | 10 | |
| DNA Template | 10nM/L | 2 |
| ddH2O | To 18 | |
| Starter (10X) | 2 |
2. Gently tap to mix several times, briefly centrifuge, repeat 3 times (mix gently to avoid vigorous vortexing).
3. Incubate at 37°C for 20 minutes.
4. After heating at 65°C for 10 minutes, proceed to gel electrophoresis.
Electrophoresis of RPA Primer Screening for COVID-19. The concentration of the tested DNA template is 1000cps/μL.
The linear graph about the efficiency verification of 7-crRNA1 of COVID-19.
The fluorescence intensity of 7-crRNA1 of COVID-19 after CRISPR reaction. No crRNA is added into negative control. The concentration of DNA template is 10nM/L.
The fluorescence intensity of crRNAs targeting Covid-19 after CRISPR reaction under Bright and UV illumination. The figures utilize pseudocolor to facilitate analysis using software (Image Lab 6). No crRNA is added into negative control. The concentration of DNA template is 10nM/L.
| None |